A
Arjan Vissink
Researcher at University Medical Center Groningen
Publications - 723
Citations - 26547
Arjan Vissink is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Implant & Medicine. The author has an hindex of 78, co-authored 668 publications receiving 22780 citations. Previous affiliations of Arjan Vissink include Lund University & University of Groningen.
Papers
More filters
Journal ArticleDOI
Oral Sequelae of Head and Neck Radiotherapy
TL;DR: In this review, the radiation-induced changes in healthy oral tissues and the resulting clinical consequences are discussed.
Journal ArticleDOI
Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
J. Pijpe,van Gustaaf Imhoff,Frederik Spijkervet,Jan L. N. Roodenburg,Gerrit Jan Wolbink,K Mansour,Arjan Vissink,Cornelis Kallenberg,Hendrika Bootsma +8 more
TL;DR: Findings of this phase II study suggest that rituximab is effective in the treatment of primary SS and MALT/primary SS and the high incidence of HACAs and associated side effects observed in this study needs further evaluation.
Journal ArticleDOI
Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
Jiska Meijer,Petra M. Meiners,Arjan Vissink,Fred K. L. Spijkervet,Wayel H. Abdulahad,N. Kamminga,Elisabeth Brouwer,Cees G. M. Kallenberg,Hendrika Bootsma +8 more
TL;DR: Rituximab treatment is an effective and safe treatment strategy for patients with primary Sjögren's syndrome and significant improvements were found in comparison with baseline values.
Journal ArticleDOI
Prevention and treatment of the consequences of head and neck radiotherapy.
TL;DR: In this review, the various possibilities for prevention and/or treatment of radiation-induced changes in healthy oral tissues and their consequences are discussed.
Journal ArticleDOI
Salivary proteomic and genomic biomarkers for primary sjögren's syndrome
Shen Hu,Jianghua Wang,Jiska Meijer,Sonya Ieong,Yongming Xie,Tianwei Yu,Hui Zhou,Sharon Henry,Arjan Vissink,J. Pijpe,Cees G. M. Kallenberg,David Elashoff,Joseph A. Loo,David T.W. Wong +13 more
TL;DR: It is found that WS contains more informative proteins, peptides, and mRNA, as compared with gland-specific saliva, that can be used in generating candidate biomarkers for the detection of primary SS.